Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro - Wikidata - awgldk - TriplyDB

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

http://www.wikidata.org/entity/Q24650946

about

In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses Pathogenesis of human immunodeficiency virus infection Sulfation of the human immunodeficiency virus envelope glycoprotein Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120 Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins Inhibition of human immunodeficiency virus type 1 RNase H by sulfated polyanions Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120 Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections Inhibition of gp120-CD4 interaction and human immunodeficiency virus type 1 infection in vitro by pyridoxal 5'-phosphate Inhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120 Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100 Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion Characterization of human immunodeficiency virus type 1 resistant to modified cyclodextrin sulphate (mCDS71) in vitro The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication Anti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactions Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase Sulfated Glycans and Related Digestive Enzymes in the Zika Virus Infectivity: Potential Mechanisms of Virus-Host Interaction and Perspectives in Drug Discovery Targeting of HIV gp120 by oligonucleotide-photosensitizer conjugates. Light-induced damages.In vitro anti-coxsackievirus B(3) effect of ethyl acetate extract of Tian-hua-fen.Simple assay to screen for inhibitors of interaction between the human immunodeficiency virus envelope glycoprotein and its cellular receptor, CD4 Anti-herpes simplex virus activities of two novel disulphated cyclitols.Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection.Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration.Designing anti-influenza aptamers: novel quantitative structure activity relationship approach gives insights into aptamer-virus interaction Sulfated polysaccharides and a synthetic sulfated polymer are potent inhibitors of Chlamydia trachomatis infectivity in vitro but lack protective efficacy in an in vivo murine model of chlamydial genital tract infection.Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.Polyanions--a lost chance in the fight against HIV and other virus diseases?Innate defences against viraemia.A tight-binding mode of inhibition is essential for anti-human immunodeficiency virus type 1 virucidal activity of nonnucleoside reverse transcriptase inhibitors.env chimeric virus technology for evaluating human immunodeficiency virus susceptibility to entry inhibitors.

P2860

Q24552626-C83C4BA9-08C8-4B93-AF8E-C19925BA84B4 Q24634681-01C633B2-8A12-4A02-BC0A-1174B790BF36 Q24647955-6F4C92CD-A4AA-4DAE-9974-3387D8853519 Q24794033-D4C4AB95-DD16-4DFC-9CEC-5E08F124F4B0 Q24806134-6399A626-DDFF-4CE4-A18B-75A11BA5BBAF Q28316430-204F71BD-79F7-4958-A0E3-2132CF0A7FAD Q28320362-BDBE21E7-B4A0-44C7-A21D-64A9857E83F9 Q28321244-22F487E9-4DCB-4F26-AFD2-DF74F5956C83 Q28323307-DCDDC81D-F394-4DE0-B759-A915773587C2 Q28324290-83C64723-3B4B-4A67-A514-0C89CCAD3508 Q28340338-9D20F3A8-CBA5-4306-AA96-B9231A84CF11 Q28344310-A2AB6C15-5F98-4E2A-8570-5AFD7249FA0B Q28362129-D477E7FD-51F7-42BC-9886-D40D9DBA87EB Q28367647-593960E4-AB20-411B-BD07-22F3B24EF8FF Q28368050-0B7DCEA5-BE4D-4DCF-B292-DA357D164C82 Q28368254-A9E080A8-A83B-4A00-9511-F561C0BE80F9 Q28368978-54C5FBA3-32A7-48C8-B507-F152C0961381 Q28369127-1BB36B97-3D42-4815-984E-79DA65A2EFB3 Q28371764-59B65299-103C-48BC-B57C-DC20486007F9 Q28378759-0290EA13-F5BB-4569-91B6-E4AC4F736542 Q28378840-D2F7AF55-5AE0-4E14-A159-E18163424664 Q28379091-4B533629-CBB7-412F-89A7-C5B35F399998 Q28379465-0965A07B-2572-4668-AFAD-6A646FADDF3B Q28379510-3972F269-4E94-450D-BD49-C7EF08747241 Q28817653-A145CFCE-BD49-4834-9129-1F0E1C3F6576 Q30830795-3196D750-407E-483D-ACBB-21C259126CDF Q33204844-A995EE65-7BE0-4465-BB45-9F3D6C9AC8CB Q33220705-F0030417-2D1E-4C09-898E-7ABCBBE61DDD Q33260475-F1EA4A21-EAAE-4CD0-B79F-02385FE46366 Q33377921-83850C37-8F26-4704-B6C1-B8F681D7506D Q33388659-F02846F7-65CD-4620-BA94-31C336111334 Q33398037-704992A1-DAAF-4EAC-9999-790E8453E5CA Q33638356-C9103AE3-82FB-442B-B59F-E44B7050191E Q33751875-DE00964F-2791-4475-B8EF-4B31C8ECF3C8 Q33854208-7055FACA-4053-4B37-9FA2-C2EF63F6138D Q33889449-9860A077-3211-4A1F-AB05-983A36E47F15 Q34009817-48960DCC-B8F5-4DDA-A212-EB21FD7415C0 Q34103163-BC3CA363-C14E-4D95-8B88-6666B5A3E040 Q34108974-FF9E1770-4351-4501-83F1-D309332E8550 Q34253200-96D4A0C5-0A9A-4887-B616-FB9E4D526333

P2860

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

http://www.wikidata.org/entity/Q24650946

description

1988 nî lūn-bûn

@nan

1988 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro

@ast

Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro

@en

Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro

@nl

type

label

Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro

@ast

Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro

@en

Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro

@nl

prefLabel

Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro

@ast

Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro

@en

Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro

@nl

P1433

Q24650946-3E039805-1C92-4711-8E77-F9CD344C4492

P1476

Q24650946-0DD40012-EEB5-451B-829F-8C22B01203C3

P2093

Q24650946-1B63203F-AC21-4715-AAEF-E45AFE29C92E

Q24650946-46545871-8EE3-4F98-AD89-B129596AE789

Q24650946-60F6744D-186D-4403-969E-E39A8AC95260

Q24650946-B9459892-8C19-407C-8259-A4D02263EE69

P2860

Q24650946-012E2C9E-99FD-47A2-8B1E-08A7FD0DE7DC

Q24650946-097E6C56-648C-47B3-9C6C-3320B788B80D

Q24650946-21415982-689E-45C5-A519-C162A6744F94

Q24650946-2A7A818B-E340-4B0A-B7E8-291827C8A34A

Q24650946-54C459D9-AB74-4823-8CDA-9167E8FE8241

Q24650946-5537205C-17AB-4610-8BD8-C67ABE10E106

Q24650946-63CBF891-BE0E-4B62-B5A3-3B60177BB1E7

Q24650946-6ABB9FAB-938D-48A6-AE85-17F31D223D43

Q24650946-8866E48D-F8E7-44ED-94DD-6AA41873253E

Q24650946-8BC524B5-52EA-486F-BC73-0AB7E318CD98

P304

Q24650946-408D0F58-7EDC-40DD-9AA4-45B82FCEE155

P31

Q24650946-10271E31-3180-4C9A-AEE2-0334BF6301DE

P356

Q24650946-F100FA0C-CB41-4F09-9797-49408F3D56E1

P407

Q24650946-046815DB-9FB4-489F-93F6-2442D2F11F7D

P433

Q24650946-4F5A7932-6D02-4604-A727-E41BA0AE4C0E

P478

Q24650946-D29D3BC1-6919-46A7-8D76-A53A73611528

P50

Q24650946-5195FB70-34F5-4D48-82DD-ECD9EED607B7

Q24650946-76B237B7-07BF-4E6E-B9E9-40D817343554

P577

Q24650946-F2C84F5C-44D8-4A0D-8AFE-0C8A0F259F2B

P5875

Q24650946-8978366E-9CAD-46BC-B73B-25ACA3FEEFAC

P698

Q24650946-21D54851-A6D1-4C63-9C38-6963E3A99985

P921

Q24650946-15874F9B-3F67-4F9B-872A-33CD1DC22A6B

P932

Q24650946-BE01ED10-4F1A-46EE-A67B-5A0A2CE494D8

P356

PNAS.85.16.6132

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro

@en

P2093

J Arnout

http://www.w3.org/2001/XMLSchema#string

J Desmyter

http://www.w3.org/2001/XMLSchema#string

M Baba

http://www.w3.org/2001/XMLSchema#string

R Pauwels

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses.

Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.

P304

6132-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.85.16.6132

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

P577

1988-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20698041

http://www.w3.org/2001/XMLSchema#string

P698

2457906

http://www.w3.org/2001/XMLSchema#string

P921

P932

281919

http://www.w3.org/2001/XMLSchema#string